These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 22258111

  • 1. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.
    Ragnarsson O, Höybye C, Jönsson PJ, Feldt-Rasmussen U, Johannsson G, Biller BM, Koltowska-Häggström M.
    Eur J Endocrinol; 2012 Apr; 166(4):593-600. PubMed ID: 22258111
    [Abstract] [Full Text] [Related]

  • 2. Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.
    Webb SM, Mo D, Lamberts SW, Melmed S, Cavagnini F, Pecori Giraldi F, Strasburger CJ, Zimmermann AG, Woodmansee WW, International HypoCCS Advisory Board.
    J Clin Endocrinol Metab; 2010 Feb; 95(2):630-8. PubMed ID: 20022992
    [Abstract] [Full Text] [Related]

  • 3. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
    Kelestimur F, Jonsson P, Molvalilar S, Gomez JM, Auernhammer CJ, Colak R, Koltowska-Häggström M, Goth MI.
    Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
    [Abstract] [Full Text] [Related]

  • 4. Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.
    Höybye C, Ragnarsson O, Jönsson PJ, Koltowska-Häggström M, Trainer P, Feldt-Rasmussen U, Biller BM.
    Eur J Endocrinol; 2010 Apr; 162(4):677-84. PubMed ID: 20089548
    [Abstract] [Full Text] [Related]

  • 5. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC, van Bunderen CC, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML.
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [Abstract] [Full Text] [Related]

  • 6. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J, Kendall-Taylor P, Erfurth EM, Price DA, Geffner M, Koltowska-Häggström M, Jönsson PJ, Wilton P, Abs R.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [Abstract] [Full Text] [Related]

  • 7. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.
    Gardner CJ, Mattsson AF, Daousi C, Korbonits M, Koltowska-Haggstrom M, Cuthbertson DJ.
    Eur J Endocrinol; 2015 Apr; 172(4):371-81. PubMed ID: 25583905
    [Abstract] [Full Text] [Related]

  • 8. Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Bunderen CC, van Varsseveld NC, Heymans MW, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML.
    Eur J Endocrinol; 2014 Dec; 171(6):717-26. PubMed ID: 25227133
    [Abstract] [Full Text] [Related]

  • 9. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
    Krzyzanowska-Mittermayer K, Mattsson AF, Maiter D, Feldt-Rasmussen U, Camacho-Hübner C, Luger A, Abs R.
    J Clin Endocrinol Metab; 2018 Feb 01; 103(2):523-531. PubMed ID: 29228199
    [Abstract] [Full Text] [Related]

  • 10. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
    Tritos NA, Johannsson G, Korbonits M, Miller KK, Feldt-Rasmussen U, Yuen KC, King D, Mattsson AF, Jonsson PJ, Koltowska-Haggstrom M, Klibanski A, Biller BM.
    J Clin Endocrinol Metab; 2014 Jun 01; 99(6):2018-29. PubMed ID: 24694339
    [Abstract] [Full Text] [Related]

  • 11. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P, KIMS Study Group.
    Growth Horm IGF Res; 2005 Oct 01; 15(5):349-59. PubMed ID: 16168692
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
    Kreitschmann-Andermahr I, Poll EM, Reineke A, Gilsbach JM, Brabant G, Buchfelder M, Fassbender W, Faust M, Kann PH, Wallaschofski H.
    Growth Horm IGF Res; 2008 Dec 01; 18(6):472-8. PubMed ID: 18829359
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
    Yuen KC, Koltowska-Häggström M, Cook DM, Fox JL, Jönsson PJ, Geffner ME, Abs R.
    Eur J Endocrinol; 2013 Oct 01; 169(4):511-9. PubMed ID: 23904277
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
    Colson A, Brooke AM, Walker D, Besser GM, Chew SL, Grossman AB, Jenkins PJ, Drake WM, Monson JP.
    Horm Res; 2006 Oct 01; 66(6):257-67. PubMed ID: 16914933
    [Abstract] [Full Text] [Related]

  • 15. Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas.
    Auer MK, Stalla GK, Stieg MR.
    Pituitary; 2016 Oct 01; 19(5):461-71. PubMed ID: 27194386
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes.
    Steele CA, MacFarlane IA, Blair J, Cuthbertson DJ, Didi M, Mallucci C, Javadpour M, Daousi C.
    Eur J Endocrinol; 2010 Oct 01; 163(4):515-22. PubMed ID: 20685833
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study.
    Verweij T, Slagboom TNA, van Varsseveld NC, van der Lely AJ, Drent ML, van Bunderen CC.
    Eur J Endocrinol; 2021 Oct 21; 185(6):793-801. PubMed ID: 34605771
    [Abstract] [Full Text] [Related]

  • 18. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
    Hoybye C, Jönsson P, Monson JP, Koltowska-Häggström M, Hána V, Geffner M, Abs R.
    Eur J Endocrinol; 2007 Nov 21; 157(5):589-96. PubMed ID: 17984238
    [Abstract] [Full Text] [Related]

  • 19. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U, Wilton P, Jonsson P, KIMS Study Group, KIMS International Board.
    Growth Horm IGF Res; 2004 Jun 21; 14 Suppl A():S51-8. PubMed ID: 15135778
    [Abstract] [Full Text] [Related]

  • 20. Preoperative growth hormone (GH) peak values during a GH releasing peptide-2 test reflect the severity of hypopituitarism and the postoperative recovery of GH secretion in patients with non-functioning pituitary adenomas.
    Soga A, Fukuda I, Kobayashi S, Tahara S, Morita A, Sugihara H.
    Endocr J; 2020 Feb 28; 67(2):167-175. PubMed ID: 31776295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.